Biotech Values

[mcbio]

Enanta is trying again to IPO—they filed an S-1/A today:

www.sec.gov/Archives/edgar/data/1177648/000119312513091763/d401292ds1a.htm

Might as well try while HCV remains hot. Enanta licensed ABT-450 to ABBV (#msg-15492225).

If @bradloncar is correct and Enanta would have a ~$250M market cap after its IPO, Enanta might well be worth a look don't you think? That valuation doesn't seem unreasonable at all to me.